Can you provide the last earnings date for EMERGENT BIOSOLUTIONS INC?
EMERGENT BIOSOLUTIONS INC (EBS) last reported earnings on 2/26/2026.
EMERGENT BIOSOLUTIONS INC (EBS) Earnings History & Surprises
NYSE:EBS • US29089Q1058
Current stock price
8.33 USD
+0.26 (+3.22%)
At close:
8.33 USD
0 (0%)
After Hours:
EBS Earnings overview
Past quarterly earnings results for EMERGENT BIOSOLUTIONS INC (EBS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 5, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.25
- Revenue Estimate
- 162.11M
Last Reported
Most Recent- Release Date
- Feb 26, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.43
- EPS Surprise
- -487.04%
- Revenue Surprise
- -32.31%
Beat Rate
Last 8 Quarters 63%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.43 | 0.11 | -487.04% | -960.00% | 148.7M | 219.68M | -32.31% | -23.63% |
| Q3 2025 | 1.06 | -0.12 | 974.59% | -22.63% | 231.1M | 195.94M | 17.94% | -21.34% |
| Q2 2025 | 0.16 | -0.49 | 132.33% | 106.90% | 140.9M | 147.83M | -4.69% | -44.68% |
| Q1 2025 | 0.71 | 0.44 | 59.77% | 20.34% | 222.2M | 221.19M | 0.46% | -26.03% |
| Q4 2024 | 0.05 | -0.50 | 110.00% | 106.49% | 194.7M | 257.21M | -24.30% | -29.61% |
| Q3 2024 | 1.37 | 0.14 | 868.88% | 385.42% | 293.8M | 300.48M | -2.22% | 8.61% |
| Q2 2024 | -2.32 | -0.95 | -143.07% | -118.87% | 254.7M | 191.9M | 32.73% | -24.62% |
| Q1 2024 | 0.59 | -0.87 | 167.93% | 118.61% | 300.4M | 222.45M | 35.04% | 81.95% |
| Q4 2023 | -0.77 | -0.19 | -301.25% | -148.39% | 276.6M | 296.47M | -6.70% | -16.36% |
| Q3 2023 | -0.48 | -0.23 | -112.80% | 62.20% | 270.5M | 239.81M | 12.80% | 12.71% |
| Q2 2023 | -1.06 | -0.49 | -115.65% | -23.26% | 337.9M | 218.33M | 54.77% | 39.23% |
| Q1 2023 | -3.17 | -1.25 | -153.11% | -1,861.11% | 165.1M | 144.71M | 14.09% | -46.31% |
| Q4 2022 | -0.31 | 0.04 | -797.57% | -106.89% | 330.7M | 299.59M | 10.38% | -54.27% |
| Q3 2022 | -1.27 | -0.06 | -1,938.96% | -252.78% | 240M | 270.98M | -11.43% | -27.05% |
| Q2 2022 | -0.86 | 0.38 | -327.06% | -360.61% | 242.7M | 273.65M | -11.31% | -38.94% |
| Q1 2022 | 0.18 | 0.13 | 42.57% | -88.24% | 307.5M | 286.41M | 7.36% | -10.35% |
| Q4 2021 | 4.50 | 4.31 | 4.38% | 22.62% | 723.2M | 698.27M | 3.57% | 24.05% |
| Q3 2021 | -0.36 | 2.37 | -115.18% | -116.44% | 329M | 491.71M | -33.09% | -14.59% |
| Q2 2021 | 0.33 | 1.56 | -78.83% | -83.33% | 397.5M | 402.92M | -1.35% | 0.71% |
| Q1 2021 | 1.53 | 1.13 | 34.91% | 15,200.00% | 343M | 362.06M | -5.26% | 78.18% |
| Q4 2020 | 3.67 | 3.22 | 14.01% | - | 583M | 569.58M | 2.36% | - |
| Q3 2020 | 2.19 | 2.14 | 2.35% | - | 385.2M | 442.31M | -12.91% | - |
| Q2 2020 | 1.98 | 0.69 | 186.89% | - | 394.7M | 297.68M | 32.59% | - |
| Q1 2020 | 0.01 | 0.01 | -0.99% | - | 192.5M | 200.89M | -4.18% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
319.17%
Max EPS beat (4)
974.59%
Min EPS beat (4)
59.77%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-2.65%
Max Revenue beat (4)
17.94%
Min Revenue beat (4)
-24.30%
Analysis
In the last 4 quarters, EBS has consistently beaten EPS estimates in all releases
EBS has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, EBS has beaten the EPS estimates by 319.2% on average.
In the last 4 quarters, EBS reported -2.6% below the revenue estimates on average.
Related analysis
EMERGENT BIOSOLUTIONS INC / EBS Earnings FAQ
Can you provide information on whether EMERGENT BIOSOLUTIONS INC beat earnings estimates in the last quarter?
EMERGENT BIOSOLUTIONS INC (EBS) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does EBS stock beat earnings estimates?
In the last 4 quarters, EMERGENT BIOSOLUTIONS INC (EBS) has beaten EPS estimates in 4 out of 4 releases.